CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT03428217 · COMPLETED
Trial details
- NCT number
- NCT03428217
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2020-08-31
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.